reduced by 10 years by the year 2004.

reduced by 5 years by the end of 2004.

reduced by 15 years by the year 2000.

unchanged.

reduced by 5 years by the year 2003.

remained at a plateau of 40,000 infections per year.

increased, but at a slower rate of 100,000 per year.

increased to 75,000 per year.

decreased to less than 10,000 per year.

decreased to 20,000 per year.

sexually transmitted infections.

anti-inflammatory therapy.

circumcision status.

gynecologic factors.

antiretroviral therapy.

it takes 8 to 12 years from infection to death in the absence of treatment.

it takes more than15 years from infection to death in the absence of treatment.

it is determined largely during the initial phase of infection.

it has three distinct phases.

it occurs in 60% to 70% of patients.

the response to antiretroviral therapy.

effect of HAART on the viral reservoirs in lymphoid tissue.

the risk for disease progression.

prospects for HIV eradication.

time from infection.

1 to 2 years.

10 years or more.

3 to 6 months.

5 to 6 years.

3 to 4 years.

Determine the patient’s HIV viral load and CD4 count.

Obtain genital herpes culture and sensitivity testing.

Change to an alternative oral drug.

Add photodynamic therapy.

Change to IV acyclovir.

checking viral load.

standard pharmacologic measures.

urodynamic testing.

clean intermittent catheterization.

antiviral therapy.

noncontrast CT for diagnosis.

hydration, analgesics, and temporary cessation of indinavir.

ureteroscopy.

changing to an alternative protease inhibitor.

extracorporeal shockwave lithotripsy.

It often responds to HAART.

Echogenic kidneys with preserved size are shown on ultrasonography.

It seldom presents as renal insufficiency.

It is more common in black patients.

It may present as proteinuria.

is related to coinfection with both HIV and a herpesvirus.

is related to activation of epithelial cells.

has an incidence that has changed little since the advent of HAART.

usually presents as renal disease.

is most common in patients who use intravenously administered drugs.